29 October 2019 2 Min Read
Aspen’s share price dips on news of R719m drug writedown
Australian regulators order the recall of heartburn, acid reflux and ulcer medicine Zantac due to possible cancer risks
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In